Connor, Clark & Lunn Investment Management Ltd. Legend Biotech Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 6,489 shares of LEGN stock, worth $272,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,489Holding current value
$272,992% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$470 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$316 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$279 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$241 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$212 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.04B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...